Provectus Pharmaceuticals Inc. Releases Video of Provecta(TM) in Action on Human Patient

KNOXVILLE, Tenn.--(BUSINESS WIRE)--Provectus Pharmaceuticals, Inc. (OTCBB: PVCT) has released a streaming video on their website, www.pvct.com, that illustrates the effectiveness of Provecta™, the company’s proprietary drug being tested for treatment of metastatic melanoma, breast cancer and liver cancer.